{"entity":{"id":"gateway-for-cancer-research","kind":"institution","name":"Gateway for Cancer Research","aka":["Gateway for Cancer Research Inc"],"tldr":"A US charity, founded in 1991, that funds only early-phase (phase I and II) clinical trials of new cancer treatments, for cancers of all types.","summary":"Gateway for Cancer Research was founded in 1991 and describes itself as one of the only nonprofits solely dedicated to funding phase I and II clinical trials for cancers of all types, according to its about page. It states that it has supported more than 254 clinical trials and funded over $126 million in research since 1991, that more than 10,000 patients have taken part in trials it funded, and that all donations directly fund early-phase clinical research. Trials in OnCo that name it as a funder include a Cedars-Sinai study of ivermectin with immunotherapy in triple-negative breast cancer. The IRS Business Master File lists revenue of about $10 million for the tax year ending June 2025.","asOf":"2026-11-04","links":[{"label":"About Gateway for Cancer Research","url":"https://gatewaycr.org/about/"},{"label":"Gateway for Cancer Research home page","url":"https://gatewaycr.org/"},{"label":"IRS record (via ProPublica Nonprofit Explorer)","url":"https://projects.propublica.org/nonprofits/organizations/731386920"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05318469"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Chicago, IL","country":"US","lat":41.878,"lng":-87.63,"institutionType":"consortium","website":"https://gatewaycr.org","programs":["Funding for phase I and II clinical trials","GateRaisers community fundraising"]},"route":"/institutions/gateway-for-cancer-research/","neighbours":{"trial":[{"id":"nct05318469","kind":"trial","name":"Ivermectin with balstilimab or pembrolizumab in metastatic triple-negative breast cancer (Cedars-Sinai phase 1/2)","route":"/trials/nct05318469/"}]}}